TCON - TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q4 2020 Results - Earnings Call Transcript
TRACON Pharmaceuticals, Inc. (TCON) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Charles Theuer - CEO Scott Brown - CFO Conference Call Participants Maury Raycroft - Jefferies Jason McCarthy - Maxim Group Bert Hazlett - BTIG Presentation Operator Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals' Fourth Quarter and Year-end 2020 Earnings Conference Call. [Operator Instructions] During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway and/or development plans and strategy. These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2019, and subsequent quarterly reports on Form 10-Q. You are cautioned not to place undue reliance on these forward-looking statements, and we
For further details see:
TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q4 2020 Results - Earnings Call Transcript